Noxopharm Ltd
NOX•Health Care•Biotechnology•Last updated: Dec 25
About
Noxopharm Ltd is a clinical-stage drug development company focused on oncology. The company is engaged in the development of innovative treatments for cancer, with its lead product candidate, Veyonda, being developed as an adjunct therapy to enhance the effectiveness of existing cancer treatments. Noxopharm operates primarily in the biotechnology segment, focusing on drug discovery and development.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- NOX
Related Shares
Investor Resources
Should you buy Noxopharm Ltd right now?
While NOX looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now